Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of the ReCor Medical Paradise System in Clinical Hypertension

NCT: NCT02649426 · ACTIVE_NOT_RECRUITING

NCT IDNCT02649426
StatusACTIVE_NOT_RECRUITING
Start Date2016-03
Completion2027-05

Brief Summary

RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.

Frequently Asked Questions

What is A Study of the ReCor Medical Paradise System in Clinical Hypertension?

A Study of the ReCor Medical Paradise System in Clinical Hypertension is a clinical trial registered under NCT02649426. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02649426?

The current status of NCT02649426 (A Study of the ReCor Medical Paradise System in Clinical Hypertension) is: ACTIVE_NOT_RECRUITING.

When did A Study of the ReCor Medical Paradise System in Clinical Hypertension start?

A Study of the ReCor Medical Paradise System in Clinical Hypertension started on 2016-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑